Cargando…

Radiomics in Triple Negative Breast Cancer: New Horizons in an Aggressive Subtype of the Disease

In the last decade, the analysis of the medical images has evolved significantly, applications and tools capable to extract quantitative characteristics of the images beyond the discrimination capacity of the investigator’s eye being developed. The applications of this new research field, called rad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mireștean, Camil Ciprian, Volovăț, Constantin, Iancu, Roxana Irina, Iancu, Dragoș Petru Teodor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836903/ https://www.ncbi.nlm.nih.gov/pubmed/35160069 http://dx.doi.org/10.3390/jcm11030616

Ejemplares similares

p53 Modulates Radiosensitivity in Head and Neck Cancers—From Classic to Future Horizons
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

New horizons in modulating the radio-sensitivity of head and neck cancer - 100 years after Warburg’ effect discovery
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Image Guided Radiotherapy (IGRT) and Delta (Δ) Radiomics—An Urgent Alliance for the Front Line of the War against Head and Neck Cancers
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Simultaneous Integrated Boost (SIB) vs. Sequential Boost in Head and Neck Cancer (HNC) Radiotherapy: A Radiomics-Based Decision Proof of Concept
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

An Underestimated Toxicity Radiation-Induced Hypothyroidism in Patients Multimodally Treated for Breast Cancer
por: Mireștean, Camil Ciprian, et al.
Publicado: (2021)

Hypofractionated Whole-Breast Irradiation Focus on Coronary Arteries and Cardiac Toxicity—A Narrative Review
por: Mireştean, Camil Ciprian, et al.
Publicado: (2022)

Micro-RNAs, the Cornerstones of the Future of Radiobiology in Head and Neck Cancers?
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Education in Radiation Oncology—Current Challenges and Difficulties
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Capecitabine—A “Permanent Mission” in Head and Neck Cancers “War Council”?
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Active Immune Phenotype in Head and Neck Cancer: Reevaluating the Iso-Effect Fractionation Based on the Linear Quadratic (LQ) Model—A Narrative Review
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Immunotherapy with PD-1 Inhibitor Nivolumab in Recurrent/Metastatic Platinum Refractory Head and Neck Cancers—Early Experiences from Romania and Literature Review
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Immunotherapy and Radiotherapy as an Antitumoral Long-Range Weapon—A Partnership with Unsolved Challenges: Dose, Fractionation, Volumes, Therapeutic Sequence
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Synergies Radiotherapy-Immunotherapy in Head and Neck Cancers. A New Concept for Radiotherapy Target Volumes—“Immunological Dose Painting”
por: Mireştean, Camil Ciprian, et al.
Publicado: (2020)

The Prognostic Value of Platelet–Lymphocyte Ratio, Neutrophil–Lymphocyte Ratio, and Monocyte–Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma (HNSCC)—A Retrospective Single Center Study and a Literature Review
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

New Challenges of Treatment for Locally Advanced Head and Neck Cancers in the Covid-19 Pandemic Era
por: Mireștean, Camil Ciprian, et al.
Publicado: (2021)

Head and Neck Low Grade Chondrosarcoma—A Rare Entity
por: Mireștean, Camil Ciprian, et al.
Publicado: (2023)

Radiotherapy challenges in COVID era
por: Mireștean, Camil Ciprian, et al.
Publicado: (2021)

MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review
por: Volovat, Simona Ruxandra, et al.
Publicado: (2020)

Triple-negative breast cancer: is there a treatment on the horizon?
por: Yao, Hui, et al.
Publicado: (2016)

Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology
por: Su, Guan-Hua, et al.
Publicado: (2022)

Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer
por: Ensenyat-Mendez, Miquel, et al.
Publicado: (2021)

The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
por: Jansson, Sara, et al.
Publicado: (2018)

Cancer and Diabetes: Predictive Factors in Patients with Metabolic Syndrome
por: Stan, Mihai Cosmin, et al.
Publicado: (2023)

Presentation and treatment of aggressive, Triple‐Negative carcinosarcoma of the breast
por: Vizgan, Niels, et al.
Publicado: (2022)

MiR-150-5p Overexpression in Triple-Negative Breast Cancer Contributes to the In Vitro Aggressiveness of This Breast Cancer Subtype
por: Sugita, Bruna M., et al.
Publicado: (2022)

Three-dimensional radiomics of triple-negative breast cancer: Prediction of systemic recurrence
por: Koh, Jieun, et al.
Publicado: (2020)

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
por: Chen, Xi, et al.
Publicado: (2012)

Subtyping Of Triple Negative Breast Carcinoma On The Basis Of RTK Expression
por: Hessel, Harald, et al.
Publicado: (2018)

Triple-negative breast cancer molecular subtyping and treatment progress
por: Yin, Li, et al.
Publicado: (2020)

Molecular stratification within triple-negative breast cancer subtypes
por: Wang, Dong-Yu, et al.
Publicado: (2019)

Molecular subtypes and precision treatment of triple-negative breast cancer
por: Zhao, Shen, et al.
Publicado: (2020)

Reassessment of Reliability and Reproducibility for Triple-Negative Breast Cancer Subtyping
por: Yu, Xinjian, et al.
Publicado: (2022)

Application of mammography-based radiomics signature for preoperative prediction of triple-negative breast cancer
por: Ge, Shuai, et al.
Publicado: (2022)

Multimodality MRI radiomics analysis of TP53 mutations in triple negative breast cancer
por: Sun, Kun, et al.
Publicado: (2023)

Disintegrin-like Protein Strategy to Inhibit Aggressive Triple-Negative Breast Cancer
por: Limam, Inès, et al.
Publicado: (2023)

Optical Redox Imaging Differentiates Triple-Negative Breast Cancer Subtypes
por: Jiang, Jinxia, et al.
Publicado: (2021)

Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis
por: Cserni, Gábor, et al.
Publicado: (2021)

Identification of Cancer-Associated Fibroblast Subtype of Triple-Negative Breast Cancer
por: Wang, Maoli, et al.
Publicado: (2022)

Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma
por: González-Martínez, Silvia, et al.
Publicado: (2020)

Radiomics of US texture features in differential diagnosis between triple-negative breast cancer and fibroadenoma
por: Lee, Si Eun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gotu3gi9um52jpsdsh0usrvsdp